INTELLIGENT BIO SOLUTIONS INC.
INBSDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
2 upcoming, 0 past
METR-NK cell（metabolic remodeling nature killer cells）
Ovary Cancer
METR-NK cell(Metabolic Remodeling Nature Killer Cells)
Ovarian Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
METR-NK cell（metabolic remodeling nature killer cells） | Phase 2 | Ovary Cancer | - | - |
METR-NK cell(Metabolic Remodeling Nature Killer Cells) | Phase 2 | Ovarian Cancer | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in INTELLIGENT BIO SOLUTIONS INC.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in INTELLIGENT BIO SOLUTIONS INC.'s (INBS) pipeline across Phase 2. Its lead program is METR-NK cell（metabolic remodeling nature killer cells） (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is INTELLIGENT BIO SOLUTIONS INC.'s next FDA catalyst?→
INTELLIGENT BIO SOLUTIONS INC.'s (INBS) next tracked catalyst is a Earnings expected November 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track INBS biotech catalysts?→
Add INBS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow INTELLIGENT BIO SOLUTIONS INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.